OneDigital Investment Advisors LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
OneDigital Investment Advisors LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$228,834
-38.0%
5,992
-7.6%
0.01%
-54.5%
Q4 2022$368,826
+44.1%
6,482
+0.2%
0.01%
+22.2%
Q3 2022$256,000
+0.8%
6,466
+12.2%
0.01%
-18.2%
Q2 2022$254,000
+10.9%
5,765
+0.3%
0.01%
+22.2%
Q1 2022$229,000
-0.9%
5,7500.0%0.01%
+12.5%
Q4 2021$231,000
+13.8%
5,750
+15.0%
0.01%0.0%
Q3 2021$203,000
-11.7%
5,000
-1.1%
0.01%
-11.1%
Q2 2021$230,000
-12.9%
5,055
-20.0%
0.01%
-25.0%
Q1 2021$264,000
+14.8%
6,321
+17.3%
0.01%0.0%
Q4 2020$230,0005,3870.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders